APO Research
Talk to an analyst

APO RESEARCH · REPORT

Felodipine Extended-Release Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Felodipine Extended-Release Tablets Market Analysis and Forecast 2026-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchFelodipine Extended-Release Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Felodipine Extended-Release Tablets Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Felodipine Extended-Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Felodipine Extended-Release Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Felodipine Extended-Release Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Felodipine Extended-Release Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Felodipine Extended-Release Tablets include By-Health, CSPC, Zhejiang Cheng Yi Pharmaceutical, Watsons, Schiff, Pfizer, Movefree, KAL and Doppelherz, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Felodipine Extended-Release Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Felodipine Extended-Release Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Felodipine Extended-Release Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Felodipine Extended-Release Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Felodipine Extended-Release Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Felodipine Extended-Release Tablets sales, projected growth trends, production technology, application and end-user industry.

Felodipine Extended-Release Tablets Segment by Company

By-Health

CSPC

Zhejiang Cheng Yi Pharmaceutical

Watsons

Schiff

Pfizer

Movefree

KAL

Doppelherz

Blackmores

AdvaCare

Felodipine Extended-Release Tablets Segment by Type

Tablets

Capsules

Felodipine Extended-Release Tablets Segment by Application

Hospital

Clinic

Pharmacy

Felodipine Extended-Release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felodipine Extended-Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Felodipine Extended-Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felodipine Extended-Release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Felodipine Extended-Release Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Felodipine Extended-Release Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Felodipine Extended-Release Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Felodipine Extended-Release Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablets Major Manufacturers Table 3. Capsules Major Manufacturers Table 4. Global Felodipine Extended-Release Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Pharmacy Major Manufacturers Table 8. Felodipine Extended-Release Tablets Industry Trends Table 9. Felodipine Extended-Release Tablets Industry Drivers Table 10. Felodipine Extended-Release Tablets Industry Opportunities and Challenges Table 11. Felodipine Extended-Release Tablets Industry Restraints Table 12. Global Felodipine Extended-Release Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Felodipine Extended-Release Tablets Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Felodipine Extended-Release Tablets Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2021-2026) Table 16. Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2027-2032) Table 17. Global Felodipine Extended-Release Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Felodipine Extended-Release Tablets Sales by Region (2021-2026) & (K Units) Table 19. Global Felodipine Extended-Release Tablets Sales by Region (2027-2032) & (K Units) Table 20. Global Felodipine Extended-Release Tablets Sales Market Share by Region (2021-2026) Table 21. Global Felodipine Extended-Release Tablets Sales Market Share by Region (2027-2032) Table 22. Global Felodipine Extended-Release Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Felodipine Extended-Release Tablets Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Felodipine Extended-Release Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Felodipine Extended-Release Tablets Sales Market Share by Manufacturers (2021-2026) Table 26. Global Felodipine Extended-Release Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Felodipine Extended-Release Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Felodipine Extended-Release Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Felodipine Extended-Release Tablets Manufacturers, Product Type & Application Table 30. Global Felodipine Extended-Release Tablets Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Felodipine Extended-Release Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Felodipine Extended-Release Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Felodipine Extended-Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Felodipine Extended-Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2021-2026) Table 37. Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2027-2032) Table 38. Global Felodipine Extended-Release Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 40. Global Felodipine Extended-Release Tablets Sales by Type (2027-2032) & (K Units) Table 41. Global Felodipine Extended-Release Tablets Sales Market Share by Type (2021-2026) Table 42. Global Felodipine Extended-Release Tablets Sales Market Share by Type (2027-2032) Table 43. Global Felodipine Extended-Release Tablets Price by Type (2021-2026) & (US$/Unit) Table 44. Global Felodipine Extended-Release Tablets Price by Type (2027-2032) & (US$/Unit) Table 45. Global Felodipine Extended-Release Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Felodipine Extended-Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Felodipine Extended-Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2021-2026) Table 49. Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2027-2032) Table 50. Global Felodipine Extended-Release Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Felodipine Extended-Release Tablets Sales by Application (2027-2032) & (K Units) Table 53. Global Felodipine Extended-Release Tablets Sales Market Share by Application (2021-2026) Table 54. Global Felodipine Extended-Release Tablets Sales Market Share by Application (2027-2032) Table 55. Global Felodipine Extended-Release Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Felodipine Extended-Release Tablets Price by Application (2027-2032) & (US$/Unit) Table 57. By-Health Company Information Table 58. By-Health Business Overview Table 59. By-Health Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. By-Health Felodipine Extended-Release Tablets Product Portfolio Table 61. By-Health Recent Development Table 62. CSPC Company Information Table 63. CSPC Business Overview Table 64. CSPC Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. CSPC Felodipine Extended-Release Tablets Product Portfolio Table 66. CSPC Recent Development Table 67. Zhejiang Cheng Yi Pharmaceutical Company Information Table 68. Zhejiang Cheng Yi Pharmaceutical Business Overview Table 69. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolio Table 71. Zhejiang Cheng Yi Pharmaceutical Recent Development Table 72. Watsons Company Information Table 73. Watsons Business Overview Table 74. Watsons Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Watsons Felodipine Extended-Release Tablets Product Portfolio Table 76. Watsons Recent Development Table 77. Schiff Company Information Table 78. Schiff Business Overview Table 79. Schiff Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Schiff Felodipine Extended-Release Tablets Product Portfolio Table 81. Schiff Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Pfizer Felodipine Extended-Release Tablets Product Portfolio Table 86. Pfizer Recent Development Table 87. Movefree Company Information Table 88. Movefree Business Overview Table 89. Movefree Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Movefree Felodipine Extended-Release Tablets Product Portfolio Table 91. Movefree Recent Development Table 92. KAL Company Information Table 93. KAL Business Overview Table 94. KAL Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. KAL Felodipine Extended-Release Tablets Product Portfolio Table 96. KAL Recent Development Table 97. Doppelherz Company Information Table 98. Doppelherz Business Overview Table 99. Doppelherz Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Doppelherz Felodipine Extended-Release Tablets Product Portfolio Table 101. Doppelherz Recent Development Table 102. Blackmores Company Information Table 103. Blackmores Business Overview Table 104. Blackmores Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Blackmores Felodipine Extended-Release Tablets Product Portfolio Table 106. Blackmores Recent Development Table 107. AdvaCare Company Information Table 108. AdvaCare Business Overview Table 109. AdvaCare Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. AdvaCare Felodipine Extended-Release Tablets Product Portfolio Table 111. AdvaCare Recent Development Table 112. North America Felodipine Extended-Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Felodipine Extended-Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 115. North America Felodipine Extended-Release Tablets Sales by Type (2027-2032) & (K Units) Table 116. North America Felodipine Extended-Release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 117. North America Felodipine Extended-Release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 118. North America Felodipine Extended-Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Felodipine Extended-Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 121. North America Felodipine Extended-Release Tablets Sales by Application (2027-2032) & (K Units) Table 122. North America Felodipine Extended-Release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 123. North America Felodipine Extended-Release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 124. North America Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Felodipine Extended-Release Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 128. North America Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 129. North America Felodipine Extended-Release Tablets Sales by Country (2027-2032) & (K Units) Table 130. North America Felodipine Extended-Release Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 131. North America Felodipine Extended-Release Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 132. United States Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 133. Canada Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 134. Mexico Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 135. Europe Felodipine Extended-Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Felodipine Extended-Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 138. Europe Felodipine Extended-Release Tablets Sales by Type (2027-2032) & (K Units) Table 139. Europe Felodipine Extended-Release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Europe Felodipine Extended-Release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Europe Felodipine Extended-Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Felodipine Extended-Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 144. Europe Felodipine Extended-Release Tablets Sales by Application (2027-2032) & (K Units) Table 145. Europe Felodipine Extended-Release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Europe Felodipine Extended-Release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Europe Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Felodipine Extended-Release Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. Europe Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 152. Europe Felodipine Extended-Release Tablets Sales by Country (2027-2032) & (K Units) Table 153. Europe Felodipine Extended-Release Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Europe Felodipine Extended-Release Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Germany Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 156. France Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 157. U.K. Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 158. Italy Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 159. Russia Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 160. Spain Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 161. Netherlands Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 162. Switzerland Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 163. Sweden Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 164. Poland Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 165. China Felodipine Extended-Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 166. China Felodipine Extended-Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 167. China Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 168. China Felodipine Extended-Release Tablets Sales by Type (2027-2032) & (K Units) Table 169. China Felodipine Extended-Release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 170. China Felodipine Extended-Release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 171. China Felodipine Extended-Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 172. China Felodipine Extended-Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 173. China Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 174. China Felodipine Extended-Release Tablets Sales by Application (2027-2032) & (K Units) Table 175. China Felodipine Extended-Release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 176. China Felodipine Extended-Release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Asia Felodipine Extended-Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 178. Asia Felodipine Extended-Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 179. Asia Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 180. Asia Felodipine Extended-Release Tablets Sales by Type (2027-2032) & (K Units) Table 181. Asia Felodipine Extended-Release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 182. Asia Felodipine Extended-Release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 183. Asia Felodipine Extended-Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia Felodipine Extended-Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 186. Asia Felodipine Extended-Release Tablets Sales by Application (2027-2032) & (K Units) Table 187. Asia Felodipine Extended-Release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 188. Asia Felodipine Extended-Release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 189. Asia Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Asia Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Asia Felodipine Extended-Release Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. Asia Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 194. Asia Felodipine Extended-Release Tablets Sales by Country (2027-2032) & (K Units) Table 195. Asia Felodipine Extended-Release Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 196. Asia Felodipine Extended-Release Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 197. Japan Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 198. South Korea Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 199. India Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 200. Australia Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 201. Taiwan Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 202. Southeast Asia Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 203. SAMEA Felodipine Extended-Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA Felodipine Extended-Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 206. SAMEA Felodipine Extended-Release Tablets Sales by Type (2027-2032) & (K Units) Table 207. SAMEA Felodipine Extended-Release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 208. SAMEA Felodipine Extended-Release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 209. SAMEA Felodipine Extended-Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 210. SAMEA Felodipine Extended-Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 211. SAMEA Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 212. SAMEA Felodipine Extended-Release Tablets Sales by Application (2027-2032) & (K Units) Table 213. SAMEA Felodipine Extended-Release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 214. SAMEA Felodipine Extended-Release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 215. SAMEA Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. SAMEA Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. SAMEA Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. SAMEA Felodipine Extended-Release Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 219. SAMEA Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 220. SAMEA Felodipine Extended-Release Tablets Sales by Country (2027-2032) & (K Units) Table 221. SAMEA Felodipine Extended-Release Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 222. SAMEA Felodipine Extended-Release Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 223. Brazil Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 224. Argentina Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 225. Chile Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 226. Colombia Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 227. Peru Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 228. Saudi Arabia Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 229. Israel Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 230. UAE Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 231. Turkey Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 232. Iran Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 233. Egypt Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Felodipine Extended-Release Tablets Distributors List Table 237. Felodipine Extended-Release Tablets Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Felodipine Extended-Release Tablets Image Figure 2. Global Felodipine Extended-Release Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Felodipine Extended-Release Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablets Image Figure 5. Capsules Image Figure 6. Global Felodipine Extended-Release Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Felodipine Extended-Release Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Pharmacy Image Figure 11. Global Felodipine Extended-Release Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Felodipine Extended-Release Tablets Revenue (2021-2032) & (US$ Million) Figure 13. Global Felodipine Extended-Release Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Felodipine Extended-Release Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2021-2032) Figure 16. Global Felodipine Extended-Release Tablets Sales (2021-2032) & (K Units) Figure 17. Global Felodipine Extended-Release Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Felodipine Extended-Release Tablets Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Felodipine Extended-Release Tablets Sales YoY (2021-2032) & (K Units) Figure 20. Europe Felodipine Extended-Release Tablets Sales YoY (2021-2032) & (K Units) Figure 21. China Felodipine Extended-Release Tablets Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Felodipine Extended-Release Tablets Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Felodipine Extended-Release Tablets Sales YoY (2021-2032) & (K Units) Figure 24. Global Felodipine Extended-Release Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Felodipine Extended-Release Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Felodipine Extended-Release Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Felodipine Extended-Release Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2021-2032) Figure 30. Global Felodipine Extended-Release Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Felodipine Extended-Release Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Felodipine Extended-Release Tablets Sales Market Share by Type (2021-2032) Figure 33. Global Felodipine Extended-Release Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Felodipine Extended-Release Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2021-2032) Figure 36. Global Felodipine Extended-Release Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Felodipine Extended-Release Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Felodipine Extended-Release Tablets Sales Market Share by Application (2021-2032) Figure 39. North America Felodipine Extended-Release Tablets Revenue Share by Type (2021-2032) Figure 40. North America Felodipine Extended-Release Tablets Sales Share by Type (2021-2032) Figure 41. North America Felodipine Extended-Release Tablets Revenue Share by Application (2021-2032) Figure 42. North America Felodipine Extended-Release Tablets Sales Share by Application (2021-2032) Figure 43. North America Felodipine Extended-Release Tablets Revenue Share by Country (2021-2032) Figure 44. North America Felodipine Extended-Release Tablets Sales Share by Country (2021-2032) Figure 45. Europe Felodipine Extended-Release Tablets Revenue Share by Type (2021-2032) Figure 46. Europe Felodipine Extended-Release Tablets Sales Share by Type (2021-2032) Figure 47. Europe Felodipine Extended-Release Tablets Revenue Share by Application (2021-2032) Figure 48. Europe Felodipine Extended-Release Tablets Sales Share by Application (2021-2032) Figure 49. Europe Felodipine Extended-Release Tablets Revenue Share by Country (2021-2032) Figure 50. Europe Felodipine Extended-Release Tablets Sales Share by Country (2021-2032) Figure 51. China Felodipine Extended-Release Tablets Revenue Share by Type (2021-2032) Figure 52. China Felodipine Extended-Release Tablets Sales Share by Type (2021-2032) Figure 53. China Felodipine Extended-Release Tablets Revenue Share by Application (2021-2032) Figure 54. China Felodipine Extended-Release Tablets Sales Share by Application (2021-2032) Figure 55. Asia Felodipine Extended-Release Tablets Revenue Share by Type (2021-2032) Figure 56. Asia Felodipine Extended-Release Tablets Sales Share by Type (2021-2032) Figure 57. Asia Felodipine Extended-Release Tablets Revenue Share by Application (2021-2032) Figure 58. Asia Felodipine Extended-Release Tablets Sales Share by Application (2021-2032) Figure 59. Asia Felodipine Extended-Release Tablets Revenue Share by Country (2021-2032) Figure 60. Asia Felodipine Extended-Release Tablets Sales Share by Country (2021-2032) Figure 61. SAMEA Felodipine Extended-Release Tablets Revenue Share by Type (2021-2032) Figure 62. SAMEA Felodipine Extended-Release Tablets Sales Share by Type (2021-2032) Figure 63. SAMEA Felodipine Extended-Release Tablets Revenue Share by Application (2021-2032) Figure 64. SAMEA Felodipine Extended-Release Tablets Sales Share by Application (2021-2032) Figure 65. SAMEA Felodipine Extended-Release Tablets Revenue Share by Country (2021-2032) Figure 66. SAMEA Felodipine Extended-Release Tablets Sales Share by Country (2021-2032) Figure 67. Felodipine Extended-Release Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Felodipine Extended-Release Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • By-Health
  • CSPC
  • Zhejiang Cheng Yi Pharmaceutical
  • Watsons
  • Schiff
  • Pfizer
  • Movefree
  • KAL
  • Doppelherz
  • Blackmores
  • AdvaCare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Felodipine Extended-Release Tablets Market by Type
  3. 1.2.1 Global Felodipine Extended-Release Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablets
  5. 1.2.3 Capsules
  6. 1.3 Felodipine Extended-Release Tablets Market by Application
  7. 1.3.1 Global Felodipine Extended-Release Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Felodipine Extended-Release Tablets Market Dynamics
  1. 2.1 Felodipine Extended-Release Tablets Industry Trends
  2. 2.2 Felodipine Extended-Release Tablets Industry Drivers
  3. 2.3 Felodipine Extended-Release Tablets Industry Opportunities and Challenges
  4. 2.4 Felodipine Extended-Release Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Felodipine Extended-Release Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Felodipine Extended-Release Tablets Revenue by Region
  3. 3.2.1 Global Felodipine Extended-Release Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Felodipine Extended-Release Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Felodipine Extended-Release Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Felodipine Extended-Release Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Felodipine Extended-Release Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Felodipine Extended-Release Tablets Sales by Region
  9. 3.4.1 Global Felodipine Extended-Release Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Felodipine Extended-Release Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Felodipine Extended-Release Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Felodipine Extended-Release Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Felodipine Extended-Release Tablets Revenue by Manufacturers
  2. 4.1.1 Global Felodipine Extended-Release Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Felodipine Extended-Release Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Felodipine Extended-Release Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Felodipine Extended-Release Tablets Sales by Manufacturers
  6. 4.2.1 Global Felodipine Extended-Release Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Felodipine Extended-Release Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Felodipine Extended-Release Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Felodipine Extended-Release Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Felodipine Extended-Release Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Felodipine Extended-Release Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Felodipine Extended-Release Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Felodipine Extended-Release Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Felodipine Extended-Release Tablets Market CR5 and HHI
  16. 4.8.2 2025 Felodipine Extended-Release Tablets Tier 1, Tier 2, and Tier 3
5 Felodipine Extended-Release Tablets Market by Type
  1. 5.1 Global Felodipine Extended-Release Tablets Revenue by Type
  2. 5.1.1 Global Felodipine Extended-Release Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Felodipine Extended-Release Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Felodipine Extended-Release Tablets Sales by Type
  6. 5.2.1 Global Felodipine Extended-Release Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Felodipine Extended-Release Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Felodipine Extended-Release Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Felodipine Extended-Release Tablets Price by Type
6 Felodipine Extended-Release Tablets Market by Application
  1. 6.1 Global Felodipine Extended-Release Tablets Revenue by Application
  2. 6.1.1 Global Felodipine Extended-Release Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Felodipine Extended-Release Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Felodipine Extended-Release Tablets Sales by Application
  6. 6.2.1 Global Felodipine Extended-Release Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Felodipine Extended-Release Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Felodipine Extended-Release Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Felodipine Extended-Release Tablets Price by Application
7 Company Profiles
  1. 7.1 By-Health
  2. 7.1.1 By-Health Company Information
  3. 7.1.2 By-Health Business Overview
  4. 7.1.3 By-Health Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 By-Health Felodipine Extended-Release Tablets Product Portfolio
  6. 7.1.5 By-Health Recent Developments
  7. 7.2 CSPC
  8. 7.2.1 CSPC Company Information
  9. 7.2.2 CSPC Business Overview
  10. 7.2.3 CSPC Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CSPC Felodipine Extended-Release Tablets Product Portfolio
  12. 7.2.5 CSPC Recent Developments
  13. 7.3 Zhejiang Cheng Yi Pharmaceutical
  14. 7.3.1 Zhejiang Cheng Yi Pharmaceutical Company Information
  15. 7.3.2 Zhejiang Cheng Yi Pharmaceutical Business Overview
  16. 7.3.3 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolio
  18. 7.3.5 Zhejiang Cheng Yi Pharmaceutical Recent Developments
  19. 7.4 Watsons
  20. 7.4.1 Watsons Company Information
  21. 7.4.2 Watsons Business Overview
  22. 7.4.3 Watsons Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Watsons Felodipine Extended-Release Tablets Product Portfolio
  24. 7.4.5 Watsons Recent Developments
  25. 7.5 Schiff
  26. 7.5.1 Schiff Company Information
  27. 7.5.2 Schiff Business Overview
  28. 7.5.3 Schiff Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Schiff Felodipine Extended-Release Tablets Product Portfolio
  30. 7.5.5 Schiff Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Felodipine Extended-Release Tablets Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Movefree
  38. 7.7.1 Movefree Company Information
  39. 7.7.2 Movefree Business Overview
  40. 7.7.3 Movefree Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Movefree Felodipine Extended-Release Tablets Product Portfolio
  42. 7.7.5 Movefree Recent Developments
  43. 7.8 KAL
  44. 7.8.1 KAL Company Information
  45. 7.8.2 KAL Business Overview
  46. 7.8.3 KAL Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 KAL Felodipine Extended-Release Tablets Product Portfolio
  48. 7.8.5 KAL Recent Developments
  49. 7.9 Doppelherz
  50. 7.9.1 Doppelherz Company Information
  51. 7.9.2 Doppelherz Business Overview
  52. 7.9.3 Doppelherz Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Doppelherz Felodipine Extended-Release Tablets Product Portfolio
  54. 7.9.5 Doppelherz Recent Developments
  55. 7.10 Blackmores
  56. 7.10.1 Blackmores Company Information
  57. 7.10.2 Blackmores Business Overview
  58. 7.10.3 Blackmores Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Blackmores Felodipine Extended-Release Tablets Product Portfolio
  60. 7.10.5 Blackmores Recent Developments
  61. 7.11 AdvaCare
  62. 7.11.1 AdvaCare Company Information
  63. 7.11.2 AdvaCare Business Overview
  64. 7.11.3 AdvaCare Felodipine Extended-Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 AdvaCare Felodipine Extended-Release Tablets Product Portfolio
  66. 7.11.5 AdvaCare Recent Developments
8 North America
  1. 8.1 North America Felodipine Extended-Release Tablets Market Size by Type
  2. 8.1.1 North America Felodipine Extended-Release Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Felodipine Extended-Release Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Felodipine Extended-Release Tablets Price by Type (2021-2032)
  5. 8.2 North America Felodipine Extended-Release Tablets Market Size by Application
  6. 8.2.1 North America Felodipine Extended-Release Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Felodipine Extended-Release Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Felodipine Extended-Release Tablets Price by Application (2021-2032)
  9. 8.3 North America Felodipine Extended-Release Tablets Market Size by Country
  10. 8.3.1 North America Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Felodipine Extended-Release Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Felodipine Extended-Release Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Felodipine Extended-Release Tablets Market Size by Type
  2. 9.1.1 Europe Felodipine Extended-Release Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Felodipine Extended-Release Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Felodipine Extended-Release Tablets Price by Type (2021-2032)
  5. 9.2 Europe Felodipine Extended-Release Tablets Market Size by Application
  6. 9.2.1 Europe Felodipine Extended-Release Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Felodipine Extended-Release Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Felodipine Extended-Release Tablets Price by Application (2021-2032)
  9. 9.3 Europe Felodipine Extended-Release Tablets Market Size by Country
  10. 9.3.1 Europe Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Felodipine Extended-Release Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Felodipine Extended-Release Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Felodipine Extended-Release Tablets Market Size by Type
  2. 10.1.1 China Felodipine Extended-Release Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Felodipine Extended-Release Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Felodipine Extended-Release Tablets Price by Type (2021-2032)
  5. 10.2 China Felodipine Extended-Release Tablets Market Size by Application
  6. 10.2.1 China Felodipine Extended-Release Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Felodipine Extended-Release Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Felodipine Extended-Release Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Felodipine Extended-Release Tablets Market Size by Type
  2. 11.1.1 Asia Felodipine Extended-Release Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Felodipine Extended-Release Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Felodipine Extended-Release Tablets Price by Type (2021-2032)
  5. 11.2 Asia Felodipine Extended-Release Tablets Market Size by Application
  6. 11.2.1 Asia Felodipine Extended-Release Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Felodipine Extended-Release Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Felodipine Extended-Release Tablets Price by Application (2021-2032)
  9. 11.3 Asia Felodipine Extended-Release Tablets Market Size by Country
  10. 11.3.1 Asia Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Felodipine Extended-Release Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Felodipine Extended-Release Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Felodipine Extended-Release Tablets Market Size by Type
  2. 12.1.1 SAMEA Felodipine Extended-Release Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Felodipine Extended-Release Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Felodipine Extended-Release Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Felodipine Extended-Release Tablets Market Size by Application
  6. 12.2.1 SAMEA Felodipine Extended-Release Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Felodipine Extended-Release Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Felodipine Extended-Release Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Felodipine Extended-Release Tablets Market Size by Country
  10. 12.3.1 SAMEA Felodipine Extended-Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Felodipine Extended-Release Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Felodipine Extended-Release Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Felodipine Extended-Release Tablets Value Chain Analysis
  2. 13.1.1 Felodipine Extended-Release Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Felodipine Extended-Release Tablets Production Mode & Process
  6. 13.2 Felodipine Extended-Release Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Felodipine Extended-Release Tablets Distributors
  9. 13.2.3 Felodipine Extended-Release Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst